With a £4.5 million pound grant from the Biotechnology and Biological Sciences Research Council (BBSRC) scientists in the UK this week began a project aiming to gain a better understanding of how new drugs could be developed to help treat cancer. Ultimately the scientists want to try and save more lives as well as money, by matching the right medication to the right patient.
The project is a collaboration between the Science and Technology Facilities Council's Rutherford Appleton Laboratory (RAL), King's College London, and Cambridge and Oxford Universities.
More at: http://www.scitech.ac.uk/PMC/PRel/STFC/RALKings.aspx
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment